{"id":"W2139560482","doi":"10.1016/s1474-4422(13)70102-9","title":"Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Placebo; Tolerability; Multiple sclerosis; Dose-ranging study; Internal medicine; Cohort; Clinical endpoint; Adverse effect; Interim analysis; Randomized controlled trial; Double blind; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000437969,0.0002284697,0.0003799935,0.0000403397,0.0002704568,0.0000471883,0.0003883132,0.0001082817,0.00001640497],"category_scores_gemma":[0.0002177986,0.0001520852,0.00008229256,0.00008339227,0.00009638373,0.00001570557,0.00009347262,0.0001748266,0.000006113178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003263826,"about_ca_system_score_gemma":0.00002473387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007238986,"about_ca_topic_score_gemma":0.00002854604,"domain_scores_codex":[0.9983369,0.0002916043,0.0002575695,0.0004895239,0.0001293114,0.0004950566],"domain_scores_gemma":[0.9988751,0.0001457474,0.0001707993,0.0005761691,0.0001471406,0.00008499766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.114566,0.004871633,0.2209546,0.00005081594,0.0007463791,0.000006467501,0.002313994,0.002615022,0.6205794,0.0001328362,0.004448721,0.02871417],"study_design_scores_gemma":[0.5781779,0.0379674,0.3078367,0.00005868586,0.000783827,0.00002899504,0.0008817955,0.01843673,0.03723435,0.0003300891,0.01628521,0.001978329],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959219,0.0001607383,0.001491565,0.0001967534,0.0002707625,0.001822306,0.00002501704,0.00003880011,0.00007212959],"genre_scores_gemma":[0.9965179,0.00002108613,0.0006709464,0.001408218,0.0008444989,0.0003814061,0.00006920398,0.00005209274,0.00003466204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.583345,"threshold_uncertainty_score":0.6201854,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03038342795681824,"score_gpt":0.2537246030815696,"score_spread":0.2233411751247514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}